Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

It's Mass Spectrometry's Turn to Change Clinical Practice.

Bodor GS.

Clin Lab Med. 2018 Sep;38(3):ix-xi. doi: 10.1016/j.cll.2018.06.001. Epub 2018 Jul 20. No abstract available.

PMID:
30115399
2.

Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry.

Bodor GS.

Clin Lab Med. 2018 Sep;38(3):455-470. doi: 10.1016/j.cll.2018.05.005. Epub 2018 Jul 20. Review.

PMID:
30115391
3.

Cardiac Troponins: Molecules of Many Surprises.

Bodor GS.

Clin Chem. 2017 Jun;63(6):1059-1060. doi: 10.1373/clinchem.2017.273094. Epub 2017 Apr 20. No abstract available.

4.

Does This Patient Have Acute Myocardial Infarction?

Bodor GS.

Clin Chem. 2017 Jan;63(1):439-440. doi: 10.1373/clinchem.2016.265751. No abstract available.

5.

Biochemical Markers of Myocardial Damage.

Bodor GS.

EJIFCC. 2016 Apr 20;27(2):95-111. eCollection 2016 Apr.

6.

What Can a Clinical Chemist Learn from Aviation?

Bodor GS.

Clin Chem. 2016 Aug;62(8):1165-6. doi: 10.1373/clinchem.2016.261040. No abstract available.

7.

Quantitative, Multidrug Pain Medication Testing by Liquid Chromatography: Tandem Mass Spectrometry (LC-MS/MS).

Bodor GS.

Methods Mol Biol. 2016;1383:223-40. doi: 10.1007/978-1-4939-3252-8_24.

PMID:
26660191
8.

A patient with widely fluctuating thyroid-stimulating hormone measurements.

Will MD, Bodor GS.

Clin Chem. 2014 Oct;60(10):1349-50. doi: 10.1373/clinchem.2013.218164. No abstract available.

9.

Commentary.

Bodor GS.

Clin Chem. 2013 Jun;59(6):890-1. doi: 10.1373/clinchem.2012.199323. No abstract available.

10.

The Laboratory's Role in Opioid Pain Medication Monitoring.

Bodor GS.

EJIFCC. 2012 Jul 18;23(2):55-62. eCollection 2012 Jul.

11.

Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays.

Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Panteghini M, Welch MJ, Wu AH, Kahn SE.

Clin Chem. 2006 Sep;52(9):1685-92. Epub 2006 Jul 20.

12.

Acute myocardial infarction associated with amphetamine use.

Waksman J, Taylor RN Jr, Bodor GS, Daly FF, Jolliff HA, Dart RC.

Mayo Clin Proc. 2001 Mar;76(3):323-6. Review.

PMID:
11243281
13.

Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials.

Christenson RH, Duh SH, Apple FS, Bodor GS, Bunk DM, Dalluge J, Panteghini M, Potter JD, Welch MJ, Wu AH, Kahn SE.

Clin Chem. 2001 Mar;47(3):431-7.

14.

Role of protein phosphatases in regulation of cardiac inotropy and relaxation.

Bokník P, Khorchidi S, Bodor GS, Huke S, Knapp J, Linck B, Lüss H, Müller FU, Schmitz W, Neumann J.

Am J Physiol Heart Circ Physiol. 2001 Feb;280(2):H786-94.

15.

Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases.

Gombosova I, Boknik P, Kirchhefer U, Knapp J, Luss H, Muller FU, Muller T, Vahlensieck U, Schmitz W, Bodor GS, Neumann J.

Am J Physiol. 1998 Jun;274(6):H2123-32. doi: 10.1152/ajpheart.1998.274.6.H2123.

PMID:
9841539
16.

Troponin I phosphorylation in the normal and failing adult human heart.

Bodor GS, Oakeley AE, Allen PD, Crimmins DL, Ladenson JH, Anderson PA.

Circulation. 1997 Sep 2;96(5):1495-500.

PMID:
9315537
17.

Impact of managed care on the economics of laboratory operation in an academic medical center.

Benge H, Bodor GS, Younger WA, Parl FF.

Arch Pathol Lab Med. 1997 Jul;121(7):689-94.

PMID:
9240903
18.

Cardiac troponin T composition in normal and regenerating human skeletal muscle.

Bodor GS, Survant L, Voss EM, Smith S, Porterfield D, Apple FS.

Clin Chem. 1997 Mar;43(3):476-84.

19.

Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue.

Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS.

Clin Chem. 1995 Dec;41(12 Pt 1):1710-5.

20.

Interaction of beta-adrenoceptor and adenosine receptor agonists on phosphorylation. Identification of target proteins in mammalian ventricles.

Neumann J, Gupta RC, Jones LR, Bodor GS, Bartel S, Krause EG, Pask HT, Schmitz W, Scholz H, Watanabe AM.

J Mol Cell Cardiol. 1995 Aug;27(8):1655-67.

PMID:
8523428
21.

Mechanisms of the contractile effects of flosequinoxan.

Zimmermann N, Bodor GS, Boknik P, Gams E, Jones LR, Neumann J, Scholz H.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Apr;351(4):385-90.

PMID:
7630429
22.

Effects of adenosine receptor and muscarinic cholinergic receptor agonists on cardiac protein phosphorylation. Influence of pertussis toxin.

Neumann J, Bokník P, Bodor GS, Jones LR, Schmitz W, Scholz H.

J Pharmacol Exp Ther. 1994 Jun;269(3):1310-8.

PMID:
8014875
23.

Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I.

Adams JE 3rd, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Dávila-Román VG, Bodor GS, Ladenson JH, Jaffe AS.

N Engl J Med. 1994 Mar 10;330(10):670-4.

24.

Cardiac troponin I. A marker with high specificity for cardiac injury.

Adams JE 3rd, Bodor GS, Dávila-Román VG, Delmez JA, Apple FS, Ladenson JH, Jaffe AS.

Circulation. 1993 Jul;88(1):101-6.

PMID:
8319322
25.

Standardization of glycohemoglobin determinations in the clinical laboratory: three years of experience.

Bodor GS, Little RR, Garrett N, Brown W, Goldstein DE, Nahm MH.

Clin Chem. 1992 Dec;38(12):2414-8.

26.

Supplemental Content

Loading ...
Support Center